A new brand name for its silicone healthcare solutions represents DuPont’s dedication to the creation of next-generation, innovative silicone solutions.
DuPont announced on Sept. 15, 2020 that it is launching DuPont Liveo, a new brand name for its silicone healthcare solutions.
According to a company press release, the name stems from the terms “live” and “to be alive” and represents DuPont’s dedication to the creation of next-generation, innovative silicone solutions. The products were previously marketed with a Dow Corning or Silastic trade name. Products and packaging material are not changing, and all locations will continue to manufacture the same products, the company reported in the press release.
The Liveo product line features pharma tubing and overmolded assemblies, transdermal and topical drug delivery systems, medical adhesives, silicone elastomers, anti-flatulent active pharmaceutical ingredients, silicone antifoams, coating, fluids, emulsions, and more, the press release said.
“We are making significant investments in both capital and resources to strengthen our strategic capabilities to support our customers’ leadership in key healthcare industry market segments, and we are particularly proud of the contribution that our teams and products have provided to our customers without disruptions during the COVID-19 pandemic outbreak,” said DuPont Liveo Healthcare Global Business Director Eugenio Toccalino, in the press release.
Source: DuPont
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.